Search results for: “oncology”
-
Xcovery appoint Giovanni Selvaggi as Chief Executive Officer
•
PALM BEACH GARDENS: Xcovery Holdings Inc. announced that Giovanni Selvaggi, M.D., has been appointed as the Chief Executive…
-
Oasmia acquires global development and commercialization rights for Cantrixil
•
UPPSALA: Oasmia Pharmaceutical AB has signed an agreement with Kazia Therapeutics, an Australian oncology-focused biotechnology company, to acquire…
-
Starpharma signs research agreement with MSD
•
MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth…
-
Starpharma Holdings Limited (ASX:SPL)
•
Click Here Starpharma Holdings Limited (ASX:SPL) share price Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company…
-
Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses
•
OSLO: Targovax ASA has entered into a research collaboration agreement with Papyrus Therapeutics to assess the potential of…
-
Targovax ASA
•
Targovax ASA (OSE:TRVX) is a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors. Targovax…
-
Malin Corporation’s investee Immunocore prices upsized Nasdaq IPO
•
DUBLIN: Malin Corporation notes that its investee company, Immunocore, has announced the pricing of its initial public offering…
-
AstraZeneca agrees to divest Viela shareholding for upto $780mn
•
STOCKHOLM: AstraZeneca Plc has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio…
-
Exact Therapeutics appoints Dr Hilary Mcelwaine-Johnn as Chief Medical Officer
•
LONDON: Exact Therapeutics AS announced the appointment of Dr Hilary McElwaine-Johnn as Chief Medical Officer. Dr McElwaine-Johnn will…
-
Ipsen appoints Gwenan White as EVP Communications and Public Affairs
•
PARIS: Ipsen announced today the appointment of Gwenan White as Executive Vice President, Communications and Public Affairs, effective…
-
AstraZeneca’s Imfinzi approved in the European Union and the UK
•
LONDON: AstraZeneca‘s Imfinzi (durvalumab) has been approved in the European Union and the UK for an additional dosing…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.